Recent Updates
Recently added Catalysts

RT-114

Phase 1

Obesity | Small molecule | Metabolic |Rani Therapeutics Holdings, Inc.|Last Updated: Mar 23, 2025

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

UNCONTROLLED
Total Trials1
Total Enrollment60

FDA Designations

No designations recorded

Clinical trial landscape

RT-114 · 1 trial · 1 indication

Phase 1 1
NCT06891287An Early Phase Study of RT-114Obesity
NOT YET_RECRUITING60 Analytics
PHASE1NOT YET_RECRUITING
An Early Phase Study of RT-114
ObesityUnlock trial analytics

Study Design & Arms

Interventions

NameTypeDescription
RT-114 is the RaniPill capsule with PG-102 for the treatment of obesityCOMBINATION_PRODUCTRT-114 is the RaniPill capsule with PG-102 for the treatment of obesity.
PG-102DRUGPG-102 is a drug for the treatment of obesity.
PlaceboOTHERThe placebo is the RaniPill with saline instead of a drug.
Unlock Study Design Details